OBESITY OR OVERWEIGHT
Clinical trials for OBESITY OR OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new OBESITY OR OVERWEIGHT trials appear
Sign up with your email to follow new studies for OBESITY OR OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early drug test for weight and diabetes shows safety focus
Disease control CompletedThis early-stage study tested a new drug called AZD5004 to see if it was safe for people to take. It involved 45 Chinese adults who were overweight or had obesity, some of whom also had type 2 diabetes. The main goal was to check for side effects and see how the drug moved throug…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE1 • Sponsor: Eccogene • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
New weekly shot shows promise in fighting obesity
Disease control CompletedThis study tested whether a new weekly injection called AZD6234 helps people with obesity or overweight lose weight. About 262 adults received either the drug or a placebo (dummy injection) for 36 weeks. The main goal was to see if the drug led to better weight loss results compa…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New weight loss pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested whether a new daily pill called AZD5004 helps people lose weight compared to a placebo (dummy pill). It involved about 310 adults who were living with obesity or were overweight and had at least one related health condition, like high blood pressure. Participant…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New weekly shot aims for major weight loss in asian population
Disease control CompletedThis study tested a new weekly injection called CagriSema to help people with overweight or obesity lose weight. It involved 331 East Asian adults and compared CagriSema's effectiveness and safety to another weight-loss medication, semaglutide. Participants received a weekly inje…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New Dual-Drug injection shows promise for significant weight loss
Disease control CompletedThis study tested a new weekly injection called CagriSema to see if it helps people with overweight or obesity lose weight. It involved 300 Chinese adults and compared CagriSema against a dummy injection and a similar existing medicine (semaglutide) over about one year. The main …
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC